Chlamydia vaccine candidate granted fast track designation by the US FDA Chlamydia infection can contribute to pelvic inflammatory diseases in…
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipeline Dren Bio deep B-cell…
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease…
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE…
February 15, 2025 08:00 ET | Source: Ontario Health Coalition TORONTO, OTTAWA, LONDON and WINDSOR, Ontario, Feb. 15, 2025 (GLOBE…
Transfer of the registered office Paris, France – (31 January 2025) — PROACTIS (ISIN code : FR0004052561) announces that its…
Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval…
Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025 Paris,…
Travl.App Launches to Empower Travelers Amidst Rising Costs and Missed Opportunities January 06, 2025 14:52 ET | Source: AI Unlimited…
Sequana Medical announces results of Extraordinary General Meeting of Shareholders and update on Convertible Financing Ghent, Belgium – 20 December…
